2 articles found
A recent study reveals that only one in three heart failure patients have insurance while annual treatment costs continue to rise above one lakh rupees raising serious concerns about healthcare affordability in India
Tata Memorial researchers warn that high-cost immunotherapies risk pushing families into poverty, urging reforms in drug pricing, insurance and quality control in generics
© H16news.online . All Rights Reserved. Designed by H16news.online